2m 2m 2m 2m 2m 2m 2m
Glaukos (GKOS)
NYSE
$134.69+$3.50 (+2.66%)
Price as of Jun 23, 2026 4:10 PM EDT- $7.7BMarket Cap
- 35.53%1-Year Change
- Medical DevicesIndustry
Glaukos (GKOS)
$134.69+$3.50 (+2.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 507.4M +32.33% | 383.5M +21.85% | 314.7M +11.26% | 282.9M -3.79% | |
Cost of Revenue | 111.8M +18.92% | 94.0M +24.42% | 75.6M +9.56% | 69.0M +3.53% | |
Gross Profit | 282.8M -2.31% | 289.5M +21.04% | 239.1M +11.81% | 213.9M -5.94% | |
Sales and Marketing Expense | 331.7M +27.03% | 261.2M +16.56% | 224.1M +16.14% | 192.9M +7.62% | |
Research and Development Expense | -150.6M +10.40% | -136.4M -1.69% | -138.8M -204.12% | 133.3M +20.07% | |
Depreciation and Amortization Expense | 27.1M +9.83% | 24.7M -0.85% | 24.9M 0.00% | 24.9M -16.01% | |
Total Operating Expenses | 482.4M +17.13% | 411.8M +11.96% | 367.8M +24.19% | 296.2M +13.81% | |
Operating Profit | -199.6M +63.12% | -122.4M -4.92% | -128.7M +56.35% | -82.3M +150.40% | |
Interest Income | 10.7M -3.52% | 11.1M +21.18% | 9.2M +285.85% | 2.4M +84.39% | |
Interest Expense | -4.6M 0.00% | -4.6M -66.33% | -13.6M -0.63% | -13.7M +2.60% | |
Interest Income and Expense and Net | 6.1M -6.00% | 6.5M +245.78% | -4.5M -132.57% | 13.7M +2.60% | |
Total Nonoperating Income and Expense | 6.6M +128.22% | -23.2M +362.20% | -5.0M -68.81% | -16.1M -1.70% | |
Income before Taxes | -193.0M +32.58% | -145.6M +8.88% | -133.7M +35.86% | -98.4M +99.79% | |
Income Taxes | -5.4M -794.03% | 771,000 -17.45% | 934,000 +21.93% | 766,000 +134.97% | |
Extraordinary Items | 112.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -187.7M +28.23% | -146.4M +8.70% | -134.7M +35.75% | -99.2M +100.03% | |
Net Income from Continuing Operations Applicable to Common | -193.0M +32.58% | -145.6M +8.88% | -133.7M +35.86% | -98.4M +99.79% | |
Basic EPS and Net Income | -3.28 +18.41% | -2.77 -0.36% | -2.78 +33.01% | -2.09 +95.33% | |
Diluted EPS and Net Income | -3.28 +18.41% | -2.77 -0.36% | -2.78 +33.01% | -2.09 +95.33% | |
Basic Weighted Average Shares | 57.2M +8.41% | 52.8M +8.92% | 48.4M +2.08% | 47.4M +2.20% | |
Diluted Weighted Average Shares | 57.2M +8.41% | 52.8M +8.92% | 48.4M +2.08% | 47.4M +2.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 90.8M -46.46% | 169.6M +81.48% | 93.5M -21.80% | 119.5M +18.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 90.8M -46.46% | 169.6M +81.48% | 93.5M -21.80% | 119.5M +18.68% | |
Total Current Assets | 475.0M +5.60% | 449.8M +13.74% | 395.5M -10.90% | 443.9M -8.69% | |
Accumulated Depreciation | 55.5M +24.60% | 44.6M +29.29% | 34.5M +26.64% | 27.2M +31.82% | |
Property and Plant and Equipment and Net | 113.3M +15.72% | 97.9M -5.18% | 103.2M +9.33% | 94.4M +36.88% | |
Total Long-Term Assets | 113.3M +15.72% | 97.9M -5.18% | 103.2M +9.33% | 94.4M +36.88% | |
Total Assets | 893.5M -8.34% | 974.8M +3.65% | 940.4M -6.18% | 1.0B -4.51% | |
Income Taxes Payable | 441,000 -93.63% | 6.9M -3.02% | 7.1M -1.65% | 7.3M -0.74% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 101.3M +34.81% | 75.1M +1.50% | 74.0M +2.29% | 72.4M +14.20% | |
Total Long-Term Debt | N/A N/A | 282.8M 0.00% | 282.8M +0.49% | 281.4M +0.49% | |
Total Long-Term Liabilities | 31.7M +41.87% | 22.4M +62.69% | 13.8M +33.80% | 10.3M +8.26% | |
Total Liabilities | 237.3M +14.20% | 207.8M -56.58% | 478.6M +1.33% | 472.4M +2.13% | |
Retained Earnings | -933.1M +25.18% | -745.4M +24.43% | -599.1M +29.00% | -464.4M +27.16% | |
Total Stockholders Equity | 656.2M -14.44% | 766.9M +66.09% | 461.8M -12.88% | 530.0M -9.73% | |
Total Shares Outstanding | 57.5M +1.89% | 56.4M +14.91% | 49.1M +2.86% | 47.8M +1.68% | |
Cash Flow | |||||
Cash from Operating Activities | -14.8M -75.88% | -61.3M +6.16% | -57.8M +74.59% | -33.1M -233.90% | |
Capital Expenditures | 7.7M +21.68% | 6.3M -68.89% | 20.2M -33.10% | 30.3M -36.66% | |
Cash from Investing Activities | -77.6M -262.27% | 47.8M +239.35% | 14.1M -68.52% | 44.8M +176.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.9M -87.02% | 91.5M +508.56% | 15.0M +140.63% | 6.3M -84.08% | |
Financials Ratio | |||||
Gross Margin | 77.97% +3.29% | 75.48% -0.66% | 75.99% +0.49% | 75.61% -2.23% | |
Operating Margin | -39.33% +23.27% | -31.91% -21.97% | -40.89% +40.53% | -29.10% +160.28% | |
Return on Assets | -20.09% +31.45% | -15.29% +10.26% | -13.86% +43.38% | -9.67% +100.33% | |
Return on Equity | -26.38% +10.71% | -23.83% -12.26% | -27.16% +52.91% | -17.76% +124.64% | |
Revenue Growth | 32.33% +47.93% | 21.85% +94.07% | 11.26% +396.93% | -3.79% -112.35% | |
Current Ratio | 4.69 -21.67% | 5.99 +12.05% | 5.34 -12.90% | 6.13 -20.05% | |
Cash Ratio | 0.90 -60.29% | 2.26 +78.80% | 1.26 -23.55% | 1.65 +3.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow